Trifluoroacetaldehyde methyl hemiacetal, 90.0%, 25g

3,6-Di(4-pyridyl)-1,2,4,5-tetrazine>98.0%(HPLC)(T)5g

2-Azaspiro[3.5]nonane hydrochloride, 95.0%, 100mg

2,4,6-Tris(benzyloxy)-1,3,5-triazine, 95+%, 5g

3-chloro-N-ethylpropanamide, 95.0%, 100mg

2-AMINO-5-BROMO-N-ISOPROPYLNICOTINAMIDE, 95.0%, 100mg

((2R,3R,5R)-3-(benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate, 97%, 100mg

1-Bromo-2-methoxy-5-methyl-3-nitrobenzene, 98%, 1g

Plan PLPH S40x/0.65 phase contrast objective

2-Amino-3-(naphthalen-2-yl)propanoic acid, 95.0%, 1g

Cyclohexene>99.0%(GC)500mL

Methyl 6-methyl-2-oxo-1,2-dihydropyridine-3-carboxylate, 97%, 1g

2-Chloro-4-(cyclopropylamino)pyrimidine-5-carboxylic acid, 95.0%, 250mg